Viewing Study NCT03266159


Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2026-02-20 @ 6:34 PM
Study NCT ID: NCT03266159
Status: WITHDRAWN
Last Update Posted: 2017-12-08
First Post: 2017-08-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumours View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dose escalation View
None Small cell lung cancer View
None Trametinib View
None GSK525762 View
None Ras-mutations View
None BET inhibitor View